Ecraid

Lennie Derde speaks about #PandemicPreparedness in @horizoneu.bsky.social Magazine
She explains the importance of a permanent clinical research infrastructure across Europe to tackle emerging #InfectiousDiseases & #AntimicrobialResistance
projects.research-and-innovation.ec.europa.eu/en/horizon-m...

@anrs-mie.bsky.social @rivm-nl.bsky.social @ecrin.bsky.social @sciensano.be

The BE READY NOW European Partnership is live! 🚀

Ecraid is supporting this initiative by building 'ever-warm' research networks & FAIR data protocols, ensuring Europe is ready to respond to threats with unprecedented speed.

🔗 Full details bit.ly/463tpBe

#PandemicPreparedness #ClinicalResearch

Today in #InternationalEducationDay

Ecraid is more than an organisation focused on clinical research. It is a place where young and early-career talent and experienced experts – from both academia and industry – connect to collaborate and learn.

Explore our Education Page: ecraid.eu/education

📣 The first site has been activated in the PIPELINE-RSV International trial & is now open for recruitment at St George's University Hospitals NHS Foundation Trust in London!

Congratulations to everyone involved in reaching this important milestone!

#RSV #Vaccination #MonoclonalAntibodies #mAbs

@id-journal.bsky.social @medsky.social @infectiousdz.bsky.social @mesamalaria.org @scievents.bsky.social

🚨 Last Call: Ecraid Foundation Science Meeting!

Today is your final chance to register for this academic event bringing together leading experts from academia, industry, and the public sector. Can’t attend this time?

You can still stay connected! Subscribe to our newsletter: bit.ly/EcraidJan26

Ecraid Foundation Science Meeting Engage with Europe’s first dedicated clinical research network for infectious diseases, meet ID experts and foster collaboration.

📢 Ecraid Foundation Science Meeting: registration deadline extended! Join industry leaders, researchers, clinicians & policy experts to discuss cutting-edge science & collaboration in infectious diseases and clinical research.
Accredited by NVMM (11 points) and ABIC
www.eventbrite.nl/e/ecraid-fou...

Read this research letter on the re-emergence of M. pneumoniae 👉 publications.ersnet.org/content/erjo...

This unexpected surge emphasises the need for continued attention to respiratory #pathogen dynamics and their impact on #PatientCare and #PublicHealth responses.
@europeanrespsoc.bsky.social

@idsky.bsky.social @medsky.social @scievents.bsky.social

Ecraid Foundation Science Meeting Engage with Europe’s first dedicated clinical research network for infectious diseases, meet ID experts and foster collaboration.

📢 Programme Update: Meet our Speakers!

We’ve added new speakers to the Ecraid Foundation Science Meeting - each track now features a detailed programme. Featured speakers include: Pontus Naucler (Karolinska Institute) Kristina Rudd (Pittsburgh University) & industry leaders.
👉🏼 Register: bit.ly/EFSM

@oxprimarycare.bsky.social @ox.ac.uk @umcutrecht.bsky.social @ecrin.bsky.social @christophercbutler.bsky.social @uantwerpen.be @lenniederde.bsky.social

🤧 The EU-funded #ECRAIDPrime trial has randomised its first 3 remote patients in the #UK this flu season — launching a patient-centric approach to expand access and community participation. This is a big step for infectious disease trials in #PrimaryCare and #Europe. 🎉 Congrats to the Oxford team!

#ECRAIDPrime #PrimaryCareResearch @christophercbutler.bsky.social @lenniederde.bsky.social @oxprimarycare.bsky.social @umcutrecht.bsky.social @ox.ac.uk @ecrin.bsky.social

Primary Care Platform Trial for Respiratory Infections Launches Third Treatment Arm | Ecraid

Europe’s first #adaptiveplatformtrial for #COVID19 and COVID-like illness in the community launched its third treatment arm, marking an important step forward in Europe's pandemic preparedness. Read about this pioneering trial on www.ecraid.eu/news/primary...

@ox.ac.uk #InfectiousDiseases #ClinicalTrials #PandemicPreparedness #ResearchInfrastructure

@ox.ac.uk

From Europe to the World: Insights from Peter Horby | Ecraid An interview with Peter Horby about Ecraid’s unique clinical trial infrastructure, and the opportunities and challenges ahead.

3 years on, Ecraid is firmly embedded in Europe’s infectious diseases research ecosystem. In this interview with Prof. Sir @peterhorby.bsky.social from the Pandemic Sciences Institute, Oxford, he discusses Ecraid’s clinical trial infrastructure & future challenges. www.ecraid.eu/articles/eur...

@medsky.social @infectiousdz.bsky.social @mesamalaria.org @scievents.bsky.social

Ecraid Foundation Science Meeting Engage with Europe’s first dedicated clinical research network for infectious diseases, meet ID experts and foster collaboration.

🚨 The countdown is on for the Ecraid Foundation Science Meeting 2026! Join us for high-impact scientific exchange and collaborative networking.
🥼 Access to infectious disease experts
🏆 Accreditation by ABIC and NVMM

Don’t miss your chance to register: www.eventbrite.nl/e/ecraid-fou...

Professionals often face fragmented workflows during#outbreaks, delaying #diagnostics and trials. An important first step is proper coordination between every local clinical and laboratory teams.

🎧Recording available!
Tune into this webinar in collaboration with @europeanrespsoc.bsky.social on #PandemicPreparedness 👇
channel.ersnet.org/media-114951...

As we close out 2025, we look back on a truly landmark year for Ecraid: one defined by growth, collaboration, and impact. Thank you to our partners, collaborators, sites, investigators, and team members for your commitment and trust.

Happy holidays, and all the best for the year ahead 🌟

🎉 Amazing milestones reached in three of our perpetual observational studies (POS)! We are tremendously proud of ALL the site teams behind these studies, for making it happen as 2025 comes to an end - a great way to wrap up the year!
Thank you!

ecraid.eu/ecraid-base/...

Announcing Module 2 of the Ecraid x @ESCMID online course on Biomedical Data & Sample Governance: 'How to design your data governance framework' in collaboration with CoMeCT, IDDO, CERCLE, @who.int and @tghn-news.bsky.social

🎧👉 www.escmid.org/education/ed...

#DataGovernance #EpidemicPreparedness

📩Our final newsletter of 2025 is out!
As we close 2025, we also say farewell to our CEO, @marcbonten.bsky.social. We are proud of what we have achieved together over the years & look ahead with confidence to 2026, welcoming @lenniederde.bsky.social onboard!
Read more & subscribe: bit.ly/Dec25Ecraid

The rationale & design of the #PNEUMO study Europe was recently published!
👉 bit.ly/3MBR6d4
Now in its final year, the studies primary goal is to estimate the incidence of pneumococcal #pneumonia & serotype prevalence among adults in Europe.
#ClinicalTrials #InfectiousDiseases #ResearchSky #IDSky

Ecraid Foundation Science Meeting Engage with Europe’s first dedicated clinical research network for infectious diseases, meet ID experts and foster collaboration.

Join the Ecraid Foundation Science Meeting on 2 February 2026 in Utrecht! This two-day academic event brings together leading experts, researchers & infectious disease opinion leaders from across Europe to advance clinical research in ID.
More info & tickets: www.eventbrite.nl/e/ecraid-fou...

@infectiousdiseases.bsky.social @medicaleducation.bsky.social @medsky.social

Trainings, talent & top science: the last Ecraid Learning Newsletter of the year is out!

Filled to the brim with exciting courses, testimonials from participants at past ones, freshly-published science and interesting interviews & blogs!
👉🏽https://bit.ly/LearningDecEcraid

@europevaccine.bsky.social